Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic ...

Pancreatic cancer is one of the deadliest forms of cancer, largely because it’s so difficult to catch early. By the time it’s ...

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer Discovery Analysis Demonstrates Transformative Sensitivity of 95% ...

Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.

Mainz Biomed (MYNZ) announced it has entered into a License and Option Agreement with Liquid Biosciences to access a portfolio of novel mRNA ...

The 10 companies participating in the 2025 Mayo Clinic and ASU MedTech Accelerator program hail from five different nations ...

Chronic Stress and Obesity Work Together to Accelerate Pancreatic Cancer Development and Growth, Study Finds Mar. 10, 2025 — A new study suggests that chronic stress and an unhealthy diet may ...

1 GAAP gross profit calculation includes marketing and promotional costs, instructional costs and services, and amortization expense of $0.5 million and $0.5 million, and $1.4 million and $1.5 million ...

Story March 13 - GRO Biosciences: The synthetic biology specialist ... by by 30% as its focuses its funds on taking its lead blood cancer drug through phase 3 trials. Story Feb. 25 - Lava ...

AstraZeneca's pan-AKT kinase inhibitor for breast cancer, which has shown efficacy in patients with hormone receptor positive, HER2-negative advanced breast cancer – regardless of their PIK3CA ...